New Delhi [India], September 14 (ANI): The approval of Bharat Biotech's COVID-19 vaccine Covaxin for Emergency use Listing (EUL) from the World Health Organisation (WHO) is expected at any time soon, said Dr VK Paul, NITI Aayog member (Health) on Tuesday.
New Delhi [India], September 14 (ANI): As India crossed the landmark of administering over 75 crore COVID-19 vaccine doses on Tuesday, Niti Aayog Member (Health) Dr VK Paul said that vaccine is a shield against the disease and is also the union government's effort to contain and ultimatel
New Delhi [India], September 9 (ANI) Vaccinating children is not a condition for reopening schools, Member-Health of NITI Aayog, VK Paul said on Thursday.
New Delhi [India], September 2 (ANI): Hyderabad-based pharmaceutical company, Biological E, is expected to launch its vaccine against coronavirus in October this year, according to Dr V K Paul, Member (Health), NITI Aayog.
New Delhi [India], August 3 (ANI): Serosurveys cannot be extrapolated to estimate mortality rates of COVID-19 or undercounting of the number of coronavirus infections as they are not meant to cover granularity at the level of the state, NITI Aayog member (health) Dr VK Paul said on Tuesda
New Delhi [India], July 27 (ANI): After trials on adults, COVID-19 vaccine manufacturing companies Biological E and Novavax are being encouraged to conduct a study on paediatrics, said Member-Health of NITI Aayog Dr VK Paul on Tuesday.
New Delhi [India], July 19 (ANI): The Government of India is holding discussions with COVID-19 manufacturers Moderna and Pfizer over several issues including indemnity waiver, Dr VK Paul, Member (Health), NITI Aayog said on Friday.
New Delhi [India], July 16 (ANI): Drugs Controller General of India (DCGI) is examining pharmaceutical major Zydus Cadila's COVID-19 vaccine for children, said Dr VK Paul, Member-Health, Niti Aayog on Friday.
New Delhi [India], July 9 (ANI): Amid the rising laxity after easing COVID restrictions and several people flouting norms while overcrowding tourist destinations, Dr VK Paul, Member-Health, NITI Aayog on Friday said that the war against the virus is not over yet.
New Delhi [India], July 9 (ANI): The Government of India is holding discussions with COVID-19 vaccine manufacturers Moderna and Pfizer over several issues including indemnity waiver, said Dr V K Paul, Member (Health), NITI Aayog on Friday.
New Delhi [India], July 2 (ANI): NITI Aayog member (Health) Dr VK Paul on Friday confirmed that India is in talks with US pharma giant Johnson & Johnson for their single-dose COVID-19 vaccine named Janssen.
New Delhi [India], July 2 (ANI): A decision on the approval of Zydus Cadila's COVID-19 vaccine Zydus Cov-D is expected soon, Dr VK Paul, Member (Health) of the NITI Aayog said on Friday, adding that the data and evaluation would determine the outcome.